Companhia Brasileira de Distribuicao (NYSE:CBD) saw an upside of 4.01% to close Monday at $4.67 after adding $0.18 on the day. The 5-day average trading volume is 1,528,640 shares of the company’s common stock. It has gained $4.75 in the past week. An average of 1,070,740 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 884,322.
CBD’s 1-month performance is -9.85% or -$0.51 on its low of $4.29 reached on 10/08/21. The company’s shares have touched a 52-week low of $2.83 and high of $8.41, with the stock’s rally to the 52-week high happening on 06/23/21. YTD, CBD has achieved 21.44% or $1.09. However, the current price is down -44.47%% from the 52-week high price.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
The company’s PE ratio for the last five years has touched a high of 56.74 and a low of 2.604. CBD stock has a beta of 1.22. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.14 while the price-to-book (PB) in the most recent quarter is 0.54.
Companhia Brasileira de Distribuicao pays an annual dividend of $0.09 per share. Its dividend yield is 1.93%. CBD’s most recent quarterly dividend payment was made on Jun. 22, when it paid $0.3997 a share compared with prior rate of $0.1052, up 73.68% from last year’s. The company latest dividend increase of $0.2945 reported on Friday April 30 2021.
It is projected that Companhia Brasileira de Distribuicao’s next ex-dividend date will be on 9-Mar. CBD is expected to distribute $0.0 as its next dividend.
Companhia Brasileira de Distribuicao’s quick ratio for the period ended March 30 was 0.60, with the current ratio over the same period at 1.00 meaning that CBD stock is not able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending March 30 was 1.10, while the total debt to equity was 1.38. In terms of profitability, the gross margin trailing 12 months is 27.20%. The trailing 12-month EBITDA margin is 9.23%. The firm’s gross profit as reported stood at $2.67 billion against revenue of $9.94 billion.
For the quarterly period ending March 30 this year, Companhia Brasileira de Distribuicao’s cash and short-term investments amounted to $1.2 billion against total debt of $17.74 billion. Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -10.5% to $51.25 billion, while revenue of $0.0 was 100.0% off the previous quarter. Analysts expected CBD to announce $0.02 per share in earnings in its latest quarter, but it posted $0.08, representing a 300.00% surprise. EBITDA for the quarter stood at more than $161.58 million. CBD stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 6.06 billion, with total debt at $17.74 billion
Let’s look briefly at Companhia Brasileira de Distribuicao (CBD) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 11 October was 44.77% to suggest the stock is trending Neutral, with historical volatility in this time period at 55.90%.
The stock’s 5-day moving average is $4.60, reflecting a +7.11% or $0.31 change from its current price. CBD is currently trading -11.89% above its 20-day SMA, -29.35% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -22.81% and +34.00% respectively.
Stochastic %K and %D was 31.37% and 31.27% and the average true range (ATR) pointed at 0.22. The RSI (14) points at 41.67%, while the 14-day stochastic is at 44.97% with the period’s ATR at 0.22. The stock’s 9-day MACD Oscillator is pointing at -0.03 and -0.16 on the 14-day charts.
In the most recent analyst report for Companhia Brasileira de Distribuicao (NYSE: CBD), BofA Securities downgraded it to an Underperform rating. They previously had a Neutral rating on the stock. Analysts offering their rating for CBD stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate CBD as a “sell,”, while 3 advise that investors “Hold.” 1 analysts have rated the stock as underweight. 0 rates the stock as overweight while 4 have offered a “buy” rating.
What is CBD’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $4.69 and a high of $10.00, with their median price target at $8.20. Looking at these predictions, the average price target given by analysts is for Companhia Brasileira de Distribuicao (CBD) stock is $8.02.